Wasatch BioLabs and Oxford Nanopore Team Up to Accelerate Methylation Sequencing Towards Clinical Use
SALT LAKE CITY and OXFORD, United Kingdom, Nov. 1, 2024 /PRNewswire/ -- Wasatch Biolabs (WBL), a disruptive R&D and high-throughput...
Pharmaceutical
Cosmos Health’s Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%
CHICAGO, IL / ACCESSWIRE / November 1, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on...
NeuroBlu: New Data Partner and Enterprise SSO Integration
Major expansion of behavioral health data with 940K+ new patient records, enterprise SSO integration, and enhanced analytics tools for deeper...
Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024
WOBURN, MA / ACCESSWIRE / November 1, 2024 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing...
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
HOUSTON, TX / ACCESSWIRE / November 1, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company...
Galecto Reports Third Quarter 2024 Financial Results
- Completed strategic review to focus on oncology and severe liver diseases - Announced acquisition of global rights to BRM-1420,...
TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update
Conference call to be held Monday, November 4, 2024, at 8:30 AM ETNEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) --...
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024
BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
iZafe Group Q3 Interim Report, July-September 2024
STOCKHOLM, SE / ACCESSWIRE / November 01, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, November 1,...
Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG
VANCOUVER, BC / ACCESSWIRE / October 31, 2024 / Verisante Technology, Inc. (TSXV:VER.H) ("Verisante") is pleased to announce a transaction...
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
BOULDER, CO / ACCESSWIRE / October 31, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
Anju’s Feasibility Flex in TA Scan Wins Best of Show at SCOPE Summit Europe
FORT LAUDERDALE, Fla., Oct. 31, 2024 /PRNewswire/ -- Anju Software recently introduced Feasibility Flex, the newest feature in the flagship...
Water Flosser Market Surges to USD 1,418.81 Million by 2030, Propelled by 5.3% CAGR – Verified Market Reports®
The water flosser market is driven by growing awareness of oral health and hygiene, with consumers increasingly seeking convenient and...
eNavvi and Cost Plus Drugs Expand Relationship to Enhance Prescription Access
LOS ANGELES, Oct. 31, 2024 /PRNewswire/ -- eNavvi, Inc., a leader in the prescription marketplace, and Mark Cuban Cost Plus...
Loftware and Signant Health Announce Availability of Integrated Clinical Supplies Labeling Solution
Automates to improve speed, enable compliance, and support scalability PORTSMOUTH, N.H., Oct. 31, 2024 /PRNewswire/ -- Loftware, the global leader...
Liviniti Supports Flexibility and Savings with Humira(R) Biosimilar Solutions
Lower cost therapeutic options added for treatment of inflammatory conditionsNatchitoches, Louisiana--(Newsfile Corp. - October 31, 2024) - Liviniti, a national...
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its “Abuse and Misuse Deterrent Transdermal System” Application
ORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that theChinese National Intellectual Property Administrant (CNIPA)...
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today...
Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant
The implant demonstrates stability and consistent drug release, supporting further analytical testing and development SARASOTA, FL, Oct. 31, 2024 (GLOBE...